Supplement analysis backed by scientific evidence · PT · ES · DE · FR

← All supplements
Moderate evidenceHeart & metabolic

Propionyl-L-Carnitine

Propionyl-L-carnitine is a carnitine ester with better uptake into vascular and cardiac tissue than plain L-carnitine, studied mainly as a drug for peripheral arterial disease. Early trials showed real walking-distance gains, but the 2021 Cochrane review — which added larger, better-controlled studies — found the effect uncertain and clinically small.

View on iHerb Ships to 180+ countries · welcome discount for new customers

What the science says

  • Walking distance in intermittent claudication: early promise, uncertain on Cochrane review Moderate evidence

    A 2013 systematic review and meta-analysis of PLC in claudication found significant improvements in maximal walking distance (roughly 50-60 m over placebo) across trials. The 2021 Cochrane review reassessed the evidence and rated certainty as low, concluding the effect on maximal and pain-free walking distance may be small or absent and that larger, better-designed trials are needed. Supervised exercise therapy remains the far stronger first-line intervention.

  • Better tissue delivery than plain L-carnitine — for vascular tissue specifically Moderate evidence

    The propionyl group improves transport across cell membranes into ischemic muscle and endothelium and supplies propionyl-CoA to the Krebs cycle, which is the rationale for testing PLC rather than L-carnitine in ischemic conditions. This is a genuine pharmacological distinction, unlike most supplement "advanced forms" — but it earns PLC a specific clinical niche, not general superiority for energy or fat loss.

  • Erectile dysfunction and heart failure data are preliminary Limited evidence

    Small trials have combined PLC (typically 2 g/day) with sildenafil in men with diabetes and ED and reported greater improvement than sildenafil alone, but these were preliminary, small, and largely from a single research group. Chronic heart failure and Peyronie's trials are similarly small. None of this reaches the standard needed for a general recommendation.

Dosage & safety

Studied doseClaudication trials used 1-2 g/day orally (usually 600 mg two to three times daily) for 6-12 months; intravenous protocols were used in hospital settings. ED adjunct studies used about 2 g/day. Note that PLC is a licensed medicine in parts of Europe (as a treatment for peripheral arterial disease and carnitine deficiency), so availability as a supplement varies by country.
SafetyGenerally well tolerated; reported effects include nausea, heartburn, diarrhea and a fishy body odor at higher doses. Carnitine supplementation increases gut bacterial production of TMAO, which has been associated with cardiovascular risk in observational work — a theoretical concern for long-term use in people who already have vascular disease, though not demonstrated as harm in the trials. May potentiate warfarin (INR monitoring advised) and may lower seizure threshold in susceptible individuals. Thyroid patients should be aware carnitine can antagonize thyroid hormone action. Prescription status varies by country; discuss with a doctor if you have PAD, heart failure, or take anticoagulants. Not banned in sport.

How to take it

TimingSplit across the day, typically 600 mg two or three times daily as in the claudication trials.
With food?With meals, which reduces the nausea and heartburn that are the usual complaints.
Worth knowingSkip sublingual sprays and "liquid carnitine" drinks — the trials used plain oral propionyl-L-carnitine at gram doses.

Interactions

With medications

  • warfarin and other coumarin anticoagulants

    Carnitine potentiates coumarin anticoagulants and has raised INR in reported cases. check INR more often when starting or stopping, and tell your prescriber

  • levothyroxine and other thyroid hormone treatment

    Carnitine acts as a peripheral antagonist of thyroid hormone action and can blunt replacement therapy. do not start it without telling the doctor managing your thyroid

Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.

Frequently asked questions

Does propionyl-L-carnitine help intermittent claudication?

Uncertain. Early trials of propionyl-L-carnitine showed walking-distance gains of roughly 50-60 m over placebo, but the 2021 Cochrane review rated certainty as low and found the effect may be small or absent. Supervised exercise therapy is the far stronger first-line option.

Is propionyl-L-carnitine better than L-carnitine?

Only for a specific niche: propionyl-L-carnitine is taken up better into blood vessels and ischemic muscle, which is why it was studied for peripheral arterial disease. That does not make it better for general energy or fat loss.

How much propionyl-L-carnitine should I take?

Claudication trials used 1-2 g/day of propionyl-L-carnitine, usually 600 mg two to three times daily with meals, for 6-12 months.

Does propionyl-L-carnitine interact with warfarin or thyroid medication?

Yes. Carnitine can raise INR with warfarin, so check INR more often when starting or stopping propionyl-L-carnitine, and it can blunt thyroid hormone replacement. Tell your prescriber before you start.

Scientific references

Where to buy

Life Extension, Optimized Carnitine, 60 Capsules

View on iHerb

Ships to 180+ countries · welcome discount for new customers

Referral link — this site may earn a commission on purchases.

Related in Heart & metabolic